CVE-2023-2444

Description

A cross site request forgery vulnerability exists in Rockwell Automation's FactoryTalk Vantagepoint. This vulnerability can be exploited in two ways. If an attacker sends a malicious link to a computer that is on the same domain as the FactoryTalk Vantagepoint server and a user clicks the link, the attacker could impersonate the legitimate user and send requests to the affected product.  Additionally, if an attacker sends an untrusted link to a computer that is not on the same domain as the server and a user opens the FactoryTalk Vantagepoint website, enters credentials for the FactoryTalk Vantagepoint server, and clicks on the malicious link a cross site request forgery attack would be successful as well.

Remediation

Solution:

  • Customers should upgrade to version 8.40 to fix the issue.

Category

7.1
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.10%
Vendor Advisory custhelp.com
Affected: Rockwell Automation FactoryTalk Vantagepoint
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-2444?
CVE-2023-2444 has been scored as a high severity vulnerability.
How to fix CVE-2023-2444?
To fix CVE-2023-2444: Customers should upgrade to version 8.40 to fix the issue.
Is CVE-2023-2444 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-2444 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-2444?
CVE-2023-2444 affects Rockwell Automation FactoryTalk Vantagepoint.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.